This study examined 50 biomarkers associated with exposure to tobacco. Biomarkers were selected from several classes of known tobacco product constituents, including (1) nicotine metabolites, (2) TSNAs, (3) metals, (4) PAHs, and (5) VOCs. A complete listing of geometric means for all 50 biomarkers among each user group can be found in eTable 2 in the Supplement.
A representative biomarker from each panel was selected for visualization of study results based on its documented association with tobacco exposure and linkage to tobacco-related disease development or adverse health effects. These biomarkers included metabolites of nicotine, tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK), lead, cadmium, naphthalene, pyrene, acrylonitrile, acrolein, and acrylamide.13 (link),31 (link),32 (link),33 (link),34 (link),35 (link),36 ,37 (link),38 (link),39 ,40 (link),41 ,42 (link) To estimate nicotine exposure, total nicotine equivalents were calculated by taking the molar sum of cotinine and trans-3′-hydroxycotinine values. Table 1 outlines the potential clinical relevance of selected biomarkers.
Free full text: Click here